The movement of DNA from the cytoplasm to the nucleus remains one of the major barriers to efficient gene transfer and expression. Without localization of DNA to the nucleus, no transcription or """"""""gene therapy"""""""" can take place. Based on our studies on intracellular trafficking of nanoparticles, we have recently discovered surface modified NPs that are taken up by cells via non-endocytic pathway, have significantly greater intracellular uptake and retention than unmodified NPs, and more importantly, these nanoparticles target to the nucleus. Our objective is to test the hypothesis that the direct nuclear delivery of modified nanoparticles would deliver the encapsulated DNA directly to the nucleus that would also enhance the level of gene expression. Our goal is to investigate the molecular mechanism of nuclear localization of modified nanoparticles and determine their efficacy as a non-viral gene expression vector. To test our hypothesis, we will use wild-type (wf)-p53 gene, a tumor suppressor gene as a model therapeutic gene, and cancer as a model pathologic condition. We propose that the nanoparticle-mediated sustained expression of wf-p53 gene in the tumor tissue would lead effective regression of tumor via induction of cell apoptosis and/or over expression of anti-angiogenic factors.
The specific aims of the proposal are: i) To investigate the formulation determinants that are critical to enhancing and sustaining the level of gene expression; ii) To investigate the molecular mechanism of nuclear-localization of modified nanoparticles; iii) To determine the therapeutic efficacy of wf-p53 gene encapsulated in modified nanoparticles in prostate cancer cell line; iv) To study the pharmacokinetics of biodistribution of modified nanoparticles via intravenous administration to achieve tumor-specific gene delivery; and v) To evaluate the efficacy of modified nanoparticles using wf-p53 gene in a murine model of prostate cancer. We anticipate that these nanoparticles can be used as an effective non-viral sustained gene expression system. Efficient nuclear delivery of nanoparticles could have far reaching implications, especially for delivery of drugs and proteins directly to the nucleus, both for therapeutic purposes and as well as to study their cellular and biochemical functions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
1R01EB003975-01A1
Application #
6920391
Study Section
Special Emphasis Panel (ZRG1-GDD (01))
Program Officer
Moy, Peter
Project Start
2005-09-01
Project End
2009-06-30
Budget Start
2005-09-01
Budget End
2006-06-30
Support Year
1
Fiscal Year
2005
Total Cost
$287,100
Indirect Cost
Name
University of Nebraska Medical Center
Department
Other Basic Sciences
Type
Schools of Pharmacy
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Adjei, Isaac M; Sharma, Blanka; Peetla, Chiranjeevi et al. (2016) Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer. J Control Release 232:83-92
Adjei, Isaac M; Peetla, Chiranjeevi; Labhasetwar, Vinod (2014) Heterogeneity in nanoparticles influences biodistribution and targeting. Nanomedicine (Lond) 9:267-78
Sharma, Blanka; Peetla, Chiranjeevi; Adjei, Isaac M et al. (2013) Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy. Cancer Lett 334:228-36
Prabha, S; Sharma, B; Labhasetwar, V (2012) Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice. Cancer Gene Ther 19:530-7
Sharma, Blanka; Ma, Wenxue; Adjei, Isaac Morris et al. (2011) Nanoparticle-mediated p53 gene therapy for tumor inhibition. Drug Deliv Transl Res 1:43-52
Peetla, Chiranjeevi; Rao, Kavitha S; Labhasetwar, Vinod (2009) Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles. Mol Pharm 6:1311-20
Jin, Shihua; Labhasetwar, Vinod (2009) Nanotechnology in urology. Urol Clin North Am 36:179-88, viii
Peetla, Chiranjeevi; Stine, Andrew; Labhasetwar, Vinod (2009) Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol Pharm 6:1264-76
Peetla, Chiranjeevi; Labhasetwar, Vinod (2009) Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir 25:2369-77
Peetla, Chiranjeevi; Labhasetwar, Vinod (2008) Biophysical characterization of nanoparticle-endothelial model cell membrane interactions. Mol Pharm 5:418-29

Showing the most recent 10 out of 14 publications